Back to Search Start Over

390P OriA362: A promising CLDN18.2/4-1BB bispecific antibody for targeting pancreatic and gastric cancers with high efficacy and safety profile.

Authors :
Yang, S.
Wu, K.
Shi, Z.
Wang, H.
Li, X.
He, X.
Source :
Annals of Oncology. 2024 Supplement 1, Vol. 35, pS157-S157. 1p.
Publication Year :
2024

Details

Language :
English
ISSN :
09237534
Volume :
35
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
178046167
Full Text :
https://doi.org/10.1016/j.annonc.2024.05.531